Q-Line Biotech
Ticker > Company >

Q-Line Biotech share price

Q-Line Biotech Ltd.

  1.75 K   0   0 NSE: QLINE SECTOR: Medical Equipment/Supplies/Accessories

587.05
-8.50 (-1.43%)
NSE: Today, 03:51 PM

Buy on Angel One

Price Summary

Today's High

₹ 617.95

Today's Low

₹ 583.1

52 Week High

₹ 622

52 Week Low

₹ 431

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1369.48 Cr.

Enterprise Value

₹ 1369.48 Cr.

No. of Shares

2.33 Cr.

P/E

24.05

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  0

CASH

0

DEBT

0

Promoter Holding

67.51 %

EPS (TTM)

₹  24.41

Sales Growth

ROE

ROCE

Profit Growth

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

Profit Growth

ROE%

ROCE %

ROA%

Net NPA%

 NIM

Debt/Equity

Price to Cash Flow

∞

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Price to Book Value

Advances Growth %

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
May 2026 67.51 0.00
Mar 2026 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of 0% over the past 3 years
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)
 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)
 Profit & Loss is not available for this company.Report us

Balance Sheet (All Figures are in Crores.)

Particulars
 Balance sheet is not available for this company.Report us
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)
 Cash Flow data is not available for this company.Report us

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY26
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Last Updated on:
Brief about Q-Line Biotech
X